Abstract
IN 1954, Livingston 1 reported persistent ataxia in two patients after treatment with diphenylhydantoin. Since then, others 2-5 have reported loss of Purkinje's cells and proliferation of Bergmann's glial layer in patients with epilepsy, lesions which were ascribed to the diphenylhydantoin treatment. Dam, 6 however, found the loss of Purkinje's cells in 32 patients with idiopathic epilepsy to be related to the frequency of grand mal seizures and not to the diphenylhydantoin medication. Loss of Purkinje's cells has been observed in cats 2,3,7 and rats 7,8 intoxicated with diphenylhydantoin, whereas application of a quantitative method for estimating the cell loss in diphenylhydantoin intoxicated pigs and monkeys revealed no such effect of diphenylhydantoin. 9,10 The aim of the present study was to investigate whether the loss of Purkinje's cells in rats intoxicated with diphenylhydantoin could be verified by using a quantitative method.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
